VANCOUVER, British Columbia -
Feb. 24, 2025 -
PRLog -- THC.CSE
THCBF ‐ OTC
TFHD.F
Vancouver, Canada – THC BioMed Intl Ltd. (the "Company") announces that the Company, through its wholly owned subsidiary, THC BioMed Ltd. Inc. (the "Subsidiary")
, has entered into agreements to sell two strata units in the Subsidiary's building located at 2550 Acland Road, Kelowna, British Columbia (the "Facility"). It is proposed that the closing of the sale of the two strata units will be completed on February 14, 2025, for an aggregate sale price of $750,000. Proceeds from the sale of the strata units are expected to be released on February 18, 2025. The Company intends to use the proceeds from the sale to pay expenses of the transactions: real estate commissions ($20,868.75), mortgage payouts ($280,143.10), property taxes ($23,840.73), and real estate fees ($2,961.88). The balance of the funds ($422,185.54) will be used by the Company to pay accounting fees, existing accounts payable and to provide working capital.
The sale price was determined by market price and negotiation with the arm's length buyer. The buyer was not a Related Person.
W: https://thcbiomed.com/
Account Phone Number